http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007137823-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09996fd2b343bfd3c7a0522b517124bf
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
filingDate 2005-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83f6bb552dfde32c700bbddd74ac2d59
publicationDate 2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2007137823-A
titleOfInvention Synergistic combination therapy to treat vitiligo
abstract A synergistic treatment for vitiligo is provided. Major treatments for the treatment of pigmented diseases characterized by vitiligo-spotted depigmentation of the skin include psoralen + UV-A, steroids, basic fibroblast growth factor (bFGF) peptide lotions or surgery Treatment. While psoralen + UV-A is effective in about 50% of cases, steroids show limited efficacy only in the case of fast-diffusing vitiligo and often recur when treatment is stopped. Any combination therapy consisting of topical application of the peptide lotion on vitiligo spots in combination with any other treatment for vitiligo treatment can also act synergistically. [Selection figure] None
priorityDate 2005-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6143723-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID641462
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505468
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100101279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9782
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP03969
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP20003
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546216
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ60487
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID53175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512946
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14173
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09038
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2247
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5IS69
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13109
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15655
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID53175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311051
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404231
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114781
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582418
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48800
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID54250

Total number of triples: 49.